References
- Stegh AH . Toward personalized cancer nanomedicine – past, present, and future . Integr. Biol.5 ( 1 ), 48 – 65 ( 2013 ).
- Chin L , AndersenJN , FutrealPA . Cancer genomics: from discovery science to personalized medicine . Nat. Med.17 ( 3 ), 297 – 303 ( 2011 ).
- Davis JC , FurstenthalL , DesaiAAet al. The microeconomics of personalized medicine: today’s challenge and tomorrow’s promise . Nat. Rev. Drug Discov.8 ( 4 ), 279 – 286 ( 2009 ).
- Hood L , FriendSH . Predictive, personalized, preventive, participatory (P4) cancer medicine . Nat. Rev. Clin. Oncol.8 ( 3 ), 184 – 187 ( 2011 ).
- Schork NJ . Time for one-person trials . Nature520 ( 7549 ), 609 – 611 ( 2015 ).
- Emanuel EJ , JoffeS , GradyC , WendlerD , PersadG . Clinical research: should patients pay to play?Sci. Transl. Med.7 ( 298 ), 298ps16 ( 2015 ).
- Hamburg MA , CollinsFS . The path to personalized medicine . N. Engl. J. Med.363 ( 4 ), 301 – 304 ( 2010 ).
- Jain KK . Role of nanobiotechnology in developing personalized medicine for cancer . Technol. Cancer Res. Treat.4 ( 6 ), 645 – 650 ( 2005 ).
- Howes PD , ChandrawatiR , StevensMM . Bionanotechnology. Colloidal nanoparticles as advanced biological sensors . Science346 ( 6205 ), 1247390 ( 2014 ).
- Theek B , RizzoLY , EhlingJ , KiesslingF , LammersT . The theranostic path to personalized nanomedicine . Clin. Transl. Imaging2 ( 1 ), 66 – 76 ( 2014 ).
- Schroeder A , HellerDA , WinslowMMet al. Treating metastatic cancer with nanotechnology . Nat. Rev. Cancer12 ( 1 ), 39 – 50 ( 2012 ).
- Ojha T , RizzoL , StormG , KiesslingF , LammersT . Image-guided drug delivery: preclinical applications and clinical translation . Expert Opin. Drug Deliv.12 ( 8 ), 1203 – 1207 ( 2015 ).
- Xie J , LeeS , ChenXY . Nanoparticle-based theranostic agents . Adv. Drug Deliv. Rev.62 ( 11 ), 1064 – 1079 ( 2010 ).
- Cai WB , ChenXY . Nanoplatforms for targeted molecular imaging in living subjects . Small3 ( 11 ), 1840 – 1854 ( 2007 ).
- Wu X , SunX , GuoZet al. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug . J. Am. Chem. Soc.136 ( 9 ), 3579 – 3588 ( 2014 ).
- Mura S , NicolasJ , CouvreurP . Stimuli-responsive nanocarriers for drug delivery . Nat. Mater.12 ( 11 ), 991 – 1003 ( 2013 ).
- Torchilin VP . Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery . Nat. Rev. Drug Discov.13 ( 11 ), 813 – 827 ( 2014 ).
- Oliva N , UntermanS , ZhangY , CondeJ , SongHS , ArtziN . Personalizing biomaterials for precision nanomedicine considering the local tissue microenvironment . Adv. Healthc. Mater.4 ( 11 ), 1584 – 1599 ( 2015 ).
- Martinez AW , PhillipsST , WhitesidesGM , CarrilhoE . Diagnostics for the developing world: microfluidic paper-based analytical devices . Anal. Chem.82 ( 1 ), 3 – 10 ( 2010 ).
- Yetisen AK , AkramMS , LoweCR . Paper-based microfluidic point-of-care diagnostic devices . Lab Chip13 ( 12 ), 2210 – 2251 ( 2013 ).
- White CC , FangD , Eung-HunK , LoberWB , YongminK . Improving healthcare quality through distributed diagnosis and home healthcare (D/sub 2/H/sub 2/) . Presented at : 1st Transdisciplinary Conference on Distributed Diagnosis and Home Healthcare, 2006. D2H2 . Arlington, VA, USA , 2–4 April 2006 .